1. Home
  2. EVAX vs PCLA Comparison

EVAX vs PCLA Comparison

Compare EVAX & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • PCLA
  • Stock Information
  • Founded
  • EVAX 2008
  • PCLA 2008
  • Country
  • EVAX Denmark
  • PCLA Japan
  • Employees
  • EVAX N/A
  • PCLA N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • PCLA Building Products
  • Sector
  • EVAX Health Care
  • PCLA Consumer Discretionary
  • Exchange
  • EVAX Nasdaq
  • PCLA Nasdaq
  • Market Cap
  • EVAX 17.8M
  • PCLA 18.6M
  • IPO Year
  • EVAX 2021
  • PCLA 2025
  • Fundamental
  • Price
  • EVAX $2.95
  • PCLA $0.48
  • Analyst Decision
  • EVAX Strong Buy
  • PCLA
  • Analyst Count
  • EVAX 2
  • PCLA 0
  • Target Price
  • EVAX $10.00
  • PCLA N/A
  • AVG Volume (30 Days)
  • EVAX 68.5K
  • PCLA 192.9K
  • Earning Date
  • EVAX 10-30-2025
  • PCLA 01-01-0001
  • Dividend Yield
  • EVAX N/A
  • PCLA N/A
  • EPS Growth
  • EVAX N/A
  • PCLA N/A
  • EPS
  • EVAX N/A
  • PCLA N/A
  • Revenue
  • EVAX $3,176,000.00
  • PCLA $5,475,228.00
  • Revenue This Year
  • EVAX N/A
  • PCLA N/A
  • Revenue Next Year
  • EVAX $425.50
  • PCLA N/A
  • P/E Ratio
  • EVAX N/A
  • PCLA N/A
  • Revenue Growth
  • EVAX 1042.45
  • PCLA 40.19
  • 52 Week Low
  • EVAX $1.20
  • PCLA $0.37
  • 52 Week High
  • EVAX $16.69
  • PCLA $9.80
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 52.92
  • PCLA 44.53
  • Support Level
  • EVAX $2.81
  • PCLA $0.42
  • Resistance Level
  • EVAX $3.04
  • PCLA $0.55
  • Average True Range (ATR)
  • EVAX 0.22
  • PCLA 0.04
  • MACD
  • EVAX -0.00
  • PCLA 0.02
  • Stochastic Oscillator
  • EVAX 69.35
  • PCLA 49.36

About EVAX Evaxion Biotech

Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

Share on Social Networks: